During the past decade, Tyler Hematology-Oncology, PA conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tyler Hematology-Oncology, PA" #1 sponsor was "Acrotech Biopharma Inc." with 1 trials, followed by "Arcus Biosciences, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "G1 Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tyler Hematology-Oncology, PA" #1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Instituto Grifols, S.A." with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Tyler Hematology-Oncology, PA" are "Pancreatic Cancer" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasm" (1 trials), "Chronic Myelomonocytic Leukemia (CMML)" (1 trials) and "Colorectal Neoplasms" (1 trials). Many other conditions were trialed in "Tyler Hematology-Oncology, PA" in a lesser frequency.

Most popular intervention types in "Tyler Hematology-Oncology, PA" are "Drug" (10 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Avastin" (1 trials), "Azacitidine" (1 trials), "BI 695502" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tyler Hematology-Oncology, PA" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Tyler Hematology-Oncology, PA". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Tyler Hematology-Oncology, PA, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tyler Hematology-Oncology, PA, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".